MOST READ IN FOOTBALLTHROUGH ITRobbie Keane reveals Claudine’s father was ’50-50′ in coronavirus battleTOP SELLERGavin Whelan has gone from League of Ireland to David Beckham’s InstagramExclusiveRIYAD RAIDMan City’s Riyad Mahrez has three luxury watches stolen in £500,000 raidPicturedAN EYEFULMeet Playboy model and football agent Anamaria Prodan bidding to buy her own clubI SAW ROORodallega saw Rooney ‘drinking like madman’ & Gerrard ‘on bar dancing shirtless’NEXT STEPJonny Hayes set to move to English Championship having been let go by CelticREF RELEASEDChampions League ref Vincic released by cops after arrest in prostitution raidKEANE DEALEx Man United youth ace David Jones says Roy Keane negotiated a contract for him”Anybody celebrating something that awful is not a football fan!”While another added: “Looks a dreadful injury, all the best for a speedy recovery, Lloris.”Lloris’ replacement Paulo Gazzaniga was then involved as Brighton bagged another before half-time to go in 2-0 at the break as crisis-hit Spurs’ nightmare spell looked to be continuing.Damn. Wishing Lloris a speedy recovery 🙏🏾🙏🏾— MissVella (@VellaJimmie) October 5, 2019 Hope Lloris gets back to full health soon. Terrible injury— *LFC6times (@Liverbird6times) October 5, 2019 Get well soon, Lloris#BHATOT— ballchatPodcast (@ballchat1) October 5, 2019 4Mauricio Pochettino insists he will not run away ‘like a kid’ despite questions over Spurs future This team is more broken than Lloris’s arm.— Ojo Emmanuel (@Freude_4) October 5, 2019 No sympathy for Tottenham aside from Lloris’ arm injury #BHATOT— Matt Bracey (@mattbracey_) October 5, 2019 DAVID DE GEA has led tributes to Hugo Lloris after the Frenchman was taken to hospital during Spurs’ game at Brighton.Tottenham’s goalkeeper was left screaming in pain after his left arm buckled under his weight as he tumbled to the floor.Lloris 🙏🏼— David de Gea (@D_DeGea) October 5, 2019 4 The left arm of Hugo Lloris buckles horribly out of shape under his bodyCredit: AFP or licensors4 Lloris falls onto his left arm after spilling an early cross to gift Brighton the lead4 The elbow buckles horribly under the body of Lloris to leave the Spurs star screaming in agonyDe Gea tweeted to show his support for his fellow keeper and simply wrote: “Lloris” followed by a praying emoji.Lloris, 32, had spilled the ball on his own line dealing with a high cross, gifting Brighton the lead through Neal Maupay in the third minute at the Amex Stadium.While the Seagulls ran off in celebration, the World Cup winning goalkeeper was left writhing in pain at the back of his own net.Worried team-mates called the Spurs medics onto the pitch where they found the team captain unable to move.Specialists first administered oxygen to the stricken star in an effort to dull the pain.And as play was held up for six minutes, they then placed a mask on the Frenchman to attempt to control his breathing.Lloris was finally lifted carefully onto a stretcher where he was carried away to the dressing rooms where morphine was administered.He was then rushed by ambulance to a local hospital.Thousands of other fans were quick to offer their support to Spurs’ shot stopper online.One posted: “Am an Arsenal fan, but the #Lloris injury looked horrific and really painful and I wish him a speedy recovery.
The Wall Street Journal: Drugmaker Led By Ex-CEOs Of Pfizer, Celgene Buys Three Painkillers STAT: Drug Makers Paid Fewer Fines For Bad Behavior In Recent Years The Wall Street Journal: Valeant Asks Its Lenders For Some Slack Study: Drugmakers Paying Fewer Fines For Breaking Federal Health Laws In its analysis, Public Citizen found that financial penalties paid by pharmaceutical manufacturers have declined in recent years. The watchdog organization is calling for an increase in enforcement efforts. In other pharmaceutical news, the Federal Trade Commission is calling for more information on a merger pending between Pfizer and Allergan. News outlets also report the latest on Valeant’s challenges. This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Pain treatment maker Centrexion Therapeutics, founded by former chief executives at Pfizer Inc. and Celgen Corp., agreed to acquire three new painkilling candidates from Germany’s Boehringer Ingelheim GmbH in a bid to expand its proprietary pipeline. Financial terms weren’t disclosed in the deal for nonopioid and nonsurgical chronic pain treatments. (Steele, 3/30) Pfizer Inc. and Allergan PLC on Wednesday said federal regulators are seeking more information on their pending merger deal, a so-called inversion that would create the world’s biggest drugmaker and move one of the top names in corporate America to a foreign country. The request from the Federal Trade Commission was “fully anticipated as part of the regulatory process,” the companies said. They still expect the deal to close in the second of this year. (Steele, 3/30) The Wall Street Journal: FTC Seeks More Information On Pfizer-Allergan Merger Valeant Pharmaceuticals International Inc. said Wednesday it was seeking more room from lenders to stave off a potential default. But stock investors were unnerved, as Valeant inched back from earlier assurances about its ability to hit financial targets required by its lenders. The Canadian drug company, struggling in recent months with questions over its accounting and business practices, said it had begun seeking a deal with lenders to give it more time to file its delayed 10-K annual report. Valeant also said it was seeking “additional cushion” from lenders on some terms of its debt. (Rapoport and McNish, 3/30) The amount of money big U.S. pharmaceutical manufacturers have paid to settle charges for violating federal health care laws has declined sharply in recent years, prompting a non-profit watchdog group to call for an increase in enforcement efforts. In a new analysis that chronicles 25 years worth of pharmaceutical industry settlements and court judgments, the group, known as Public Citizen, found that just $2.4 billion in federal financial penalties were recovered from 2014 to 2015 – a figure that is less than one third of the $8.7 billion recovered from 2012 to 2013. (Lynch, 3/31) Reuters: Decline In Financial Settlements With U.S. Big Pharma: Report After a decade in which drug makers regularly paid huge fines for various fraudulent practices, there was a noticeable drop over the past two years, according to a new analysis by Public Citizen, the consumer advocacy group. (Silverman, 3/30)